Advanced lipid testing and CIMT are frequently used to approximate risk of CV events. Traditionally these tools have been used to help determine how much and what type of intervention is ideal for a particular patient, and is usually applied to choosing type and dosage of medication. Dietary, exercise and stress
modification intervention is presumed to lower risk, but in practice is not expected to make a big impact on these biomarkers.
The presenter has a large population of patients to draw from who have had advanced biomarker testing and have made significant lifestyle changes. She will present a few cases to illustrate the types of effects lifestyle changes may have on these CV biomarkers. The cases will be reviewed in detail with the group,
using the group input to understand the tests and the impact their lifestyle changes have made on their risk levels.
29 авг 2024